PT  - JOURNAL ARTICLE
AU  - Mann, Kate
TI  - Novel Once-Weekly Omarigliptin as Effective and Well Tolerated as Once-Daily Sitagliptin in Japanese Patients
DP  - 2014 Dec 01
TA  - MD Conference Express
PG  - 26--27
VI  - 14
IP  - 32
4099  - http://mdc.sagepub.com/content/14/32/26.short
4100  - http://mdc.sagepub.com/content/14/32/26.full
AB  - Patient adherence to glucose-lowering medications is a major challenge in type 2 diabetes mellitus. It is thought that an effective, well-tolerated, weekly oral antihyperglycemic agent could provide better glycemic control due to increased adherence. This article examines results of the MK-3102 Phase III Clinical Trial [NCT01703221], which evaluated the safety and efficacy of the novel dipeptidyl peptidase-4 inhibitor omarigliptin compared with placebo and sitagliptin in Japanese patients with type 2 diabetes mellitus.